ArticleCureus2026
Very Late-Onset Generalized Myasthenia Gravis Presenting With Worsening Frailty.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Very Late-Onset Myasthenia Gravis in a Very Elderly Patient: Diagnostic Challenges and Importance of Early Recognition.Geriatrics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Very late-onset myasthenia gravis, defined as disease onset after 75 years of age, is a rare but increasingly recognized clinical entity due to population aging and improved access to diagnostics. We report the case of a woman who was in her 80s and presented with progressive fatigability, bulbar symptoms, and functional decline, initially misattributed to normal aging and degenerative conditions. Clinical examination revealed fluctuating ptosis and proximal muscle weakness, and bedside ice pack testing supported a diagnosis of myasthenia gravis (MG). Serological testing confirmed elevated acetylcholine receptor antibodies. She responded well to a combination of pyridostigmine, low-dose corticosteroids, and mycophenolate mofetil, with improvement tracked via the Quantitative Myasthenia Gravis (QMG) score. This case illustrates the diagnostic challenges of MG in older adults and emphasizes the importance of recognizing reversible causes of frailty. It also highlights the geriatric principle of aligning care with what matters most to the individual, preserving function, independence, and identity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.